On this episode, we feature Dr. Chris Ho, Owner of Drug Design Methodologies, which develops software to optimize and measure drug-target binding, which ultimately helps accelerate and de-risk drug development.
On this episode, we feature Dr. Chris Ho, Owner of Drug Design Methodologies, which develops software to optimize and measure drug-target binding, which ultimately helps accelerate and de-risk drug development.